Författare: Dahlöf Carl, Ehrenborg Agneta
Titel: Migrän i ett kvinnligt perspektiv (serie: Tema huvudvärk) 2007 nr 23 sid 1812-4
Ämnesord:
Migränsjukdomar
P-piller, hormonella
Hormonersättningsbehandling
Kvinnlig
Könsfaktorer
Kvinnohälsa
Sök liknande artiklar
Referenser:
1.Welch KM, Darnley D, Simkins RT. The role of estrogen in migraine: a review and hypothesis. Cephalalgia 1984;4(4):227-36.
2.Gupta VK. Migraine and sex hormones: epidemiological data stimulate rethinking of etiologic role of estrogen. Headache 2004;44(9):933-4.
3.Martin VT, Wernke S, Mandell K, Ramadan N, Kao L, Bean J, et al. Defining the relationship between ovarian hormones and migraine headache. Headache 2005;45(9):1190-201.
4.Gupta S, Mehrotra S, Villalon CM, Perusquia M, Saxena PR, Maassenvandenbrink A. Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Ther 2006.
5.Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 2006;101(4):1252-61.
6.Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part I. Headache 2006;46(1):3-23.
7.Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part 2. Headache 2006;46(3):365-86.
8.Massiou H, MacGregor EA. Influence of female hormones on migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The Headaches. 3rd ed: Lippincott Williams & Wilkins; 2006. p. 331-342.
9.Sachs M, Pape HC, Speckmann EJ, Gorji A. The effect of estrogen and progesterone on spreading depression in rat neocortical tissues. Neurobiol Dis 2006.
10.Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 2004;5(2):129-33.
11.Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR. Investigation of hormone receptor genes in migraine. Neurogenetics 2005;6(1):17-23.
12.Brandes JL. The influence of estrogen on migraine: a systematic review. Jama 2006;295(15):1824-30.
13.Dawson-Basoa MB, Gintzler AR. 17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res 1993;601(1-2):241-5.
14.Cahill CA. Beta-endorphin levels during pregnancy and labor: a role in pain modulation? Nurs Res 1989;38(4):200-3.
15.Loder EW. Menstrual migraine: pathophysiology, diagnosis, and impact. Headache 2006;46 Suppl 2:S55-60.
16.MacGregor A. Migraine associated with menstruation. Funct Neurol 2000;3:143-53.
17.MacGregor EA. "Menstrual" migraine: towards a definition. Cephalalgia 1996;16(1):11-21.
18.Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd edition. Cephalalgia. 2004;24 Suppl 1:1-160.
19.MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004;63(2):351-3.
20.Somerville BW. The influence of progesterone and estradiol upon migraine. Headache 1972;12(3):93-102.
21.Magos AL, Zilkha KJ, Studd JW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry 1983;46(11):1044-6.
22.Amir BY, Yaacov B, Guy B, Gad P, Itzhak W, Gal I. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment. Headache 2005;45(3):215-9.
23.Massiou H, MacGregor EA. Evolution and treatment of migraine with oral contraceptives. Cephalalgia 2000;20(3):170-4.
24.Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004;24(9):707-16.
25.Martin VT, Wernke S, Mandell K, Ramadan N, Kao L, Bean J, et al. Symptoms of premenstrual syndrome and their association with migraine headache. Headache 2006;46(1):125-37.
26.Somerville BW. A study of migraine in pregnancy. Neurology 1972;22(8):824-8.
27.Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993;33(7):385-9.
28.Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy. Cephalalgia 1997;17(7):765-9.
29.Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999;39(9):625-32.
30.Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003;23(3):197-205.
31.Petersson M, Alster P, Lundeberg T, Uvnas-Moberg K. Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats. Neurosci Lett 1996;212(2):87-90.
32.Dahlöf C, Riman E. How does the IHS Classification perform in a European Headache Clinic? In: Olesen J, editor. Headache Classification and Epidemiology. New York: Raven Press; 1994. p. 77-86.
33.Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998;179(3 Pt 1):577-82.
34.Petitti DB. Clinical practice. Combination estrogen-progestin oral contraceptives. N Engl J Med 2003;349(15):1443-50.
35.Loder EW, Buse DC, Golub JR. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice. Headache 2005;45(3):224-31.
36.Allais G, De Lorenzo C, Mana O, Benedetto C. Oral contraceptives in women with migraine: balancing risks and benefits. Neurol Sci 2004;25(3):S211-4.
37.Ertresvag JM, Zwart JA, Helde G, Johnsen HJ, Bovim G. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 2005;111(4):233-7.
38.Bousser MG. International Headache Society (IHS) Task Force on oral contraceptives (OCs) and hormone replacement therapy (HRT) used in migraine sufferers. Cephalalgia 2000;20(3):145-6.
39.Bousser MG. Estrogens, migraine, and stroke. Stroke 2004;35(11 Suppl 1):2652-6.
40.Bousser MG, Conard J, Kittner S, de Lignieres B, MacGregor EA, Massiou H, et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 2000;20(3):155-6.
41.Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81(4):1495-501.
42.Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache 2003;43(5):470-8.
43.Hodson J, Thompson J, al-Azzawi F. Headache at menopause and in hormone replacement therapy users. Climacteric 2000;3(2):119-24.
44.Facchinetti F, Nappi RE, Tirelli A, Polatti F, Nappi G. Hormone supplementation differently affects migraine in postmenopausal women. Headache 2002;42(9):924-9.
45.Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993;17(1):31-7.
46.MacGregor EA. Migraine and the menopause. J Br Menopause Soc 2006;12(3):104-8.
47.Misakian AL, Langer RD, Bensenor IM, Cook NR, Manson JE, Buring JE, et al. Postmenopausal hormone therapy and migraine headache. J Womens Health (Larchmt) 2003;12(10):1027-36.
48.MacGregor EA. Female sex hormones and migraine. Rev Neurol (Paris) 2005;161(6-7):677-8.
49.Granella F, Sances G, Messa G, de Marinis M, Manzoni GC. Treatment of menstrual migraine. Cephalalgia 1997;20(1):35-8.
50.Ashkenazi A, Silberstein SD. Hormone-related headache: pathophysiology and treatment. CNS Drugs 2006;20(2):125-41.
51.Sulak P, Willis S, Kuehl T, Coffee A, Clark J. Headaches and Oral Contraceptives: Impact of Eliminating the Standard 7-Day Placebo Interval. Headache 2007;47:27-37.
52.Martin V, Wernke S, Mandell K, Zoma W, Bean J, Pinney S, et al. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003;43(4):309-21.
53.Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG, et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001;41(3):248-56.
54.Tepper SJ. Tailoring management strategies for the patient with menstrual migraine: focus on prevention and treatment. Headache 2006;46 Suppl 2:S61-8.
